NAGLU and Alzheimer disease: Therefore, NAGLU may be directly or indirectly involved in β-amyloid clearance, suggesting that NAGLU overexpression, or administering its agonist if it exists, could treat AD in experimental animal models, and NAGLU could be a potential intervention target to alleviate AD symptoms in humans.